Sign in

CIK 0001689375

  • Accelerated filer
  • Smaller reporting company
  • Emerging growth company

Entrada Therapeutics, Inc.

Sign in to watch
Ticker
TRDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813983399
Phone
+1 857-305-1825
Business address
ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, MA, 02210
Former names
CycloPorters, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$7,200,939
in 8 filings

Net −$7,200,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-11-02 5AM Ventures V, L.P. 10% owner Conversion · Series A Preferred Stock −17,161,644 0
2021-11-02 5AM Ventures V, L.P. 10% owner Conversion · Series A Preferred Stock −4,082,613 0
2021-11-02 5AM Ventures V, L.P. 10% owner Conversion · Series B Preferred Stock −1,841,620 0
2021-11-02 5AM Ventures V, L.P. 10% owner Conversion · Series B Preferred Stock −2,302,026 0
2021-11-02 MPM BIOVENTURES 2018, L.P. 10% owner Conversion +3,816,760 3,816,760
2021-11-02 MPM BIOVENTURES 2018, L.P. 10% owner Conversion +509,024 4,325,784
2021-11-02 MPM BIOVENTURES 2018, L.P. 10% owner Purchase +100,000 $20.00 $2.0M 4,425,784
2021-11-02 MPM BIOVENTURES 2018, L.P. 10% owner Conversion · Series A Preferred Stock −27,617,675 0
2021-11-02 MPM BIOVENTURES 2018, L.P. 10% owner Conversion · Series B Preferred Stock −3,683,241 0
2021-11-02 MPM BioVentures 2014, L.P. 10% owner Conversion +3,816,760 3,816,760
2021-11-02 MPM BioVentures 2014, L.P. 10% owner Conversion +509,024 4,325,784
2021-11-02 MPM BioVentures 2014, L.P. 10% owner Purchase +100,000 $20.00 $2.0M 4,425,784
2021-11-02 MPM BioVentures 2014, L.P. 10% owner Conversion · Series A Preferred Stock −27,617,675 0
2021-11-02 MPM BioVentures 2014, L.P. 10% owner Conversion · Series B Preferred Stock −3,683,241 0
2021-11-02 Foley Todd Director Conversion +3,816,760 3,816,760
2021-11-02 Foley Todd Director Conversion +509,024 4,325,784
2021-11-02 Foley Todd Director Purchase +100,000 $20.00 $2.0M 4,425,784
2021-11-02 Foley Todd Director Conversion · Series A Preferred Stock −27,617,675 0
2021-11-02 Foley Todd Director Conversion · Series B Preferred Stock −3,683,241 0
2021-11-02 ROCHE HOLDING LTD 10% owner Conversion +2,495,385 2,495,385

Page 28 of 29 · 577 trades